Are drug companies overcharging?

How much profit should drug companies make? The question might seem a little abstract, something that belongs in a business journal. But it’s one that is increasingly affecting all of us. That was abundantly clear in the wake of the latest price hike controversy to hit the headlines.

I’m not an “anti-big pharma” type, but you gotta admit that the recent revelation about the price hikes of EpiPen, a drug I used to have to carry with me everywhere, are alarming and very disturbing.

This entry was tagged: , , .   Bookmark the permalink.   Follow any comments here with the RSS feed for this post.   Both comments and trackbacks are currently closed.